Delivery Order SPE2DB24D2205-SPE2DB25FEFKC
- Not listed
- The Defense Logistics Agency awarded a $3,310.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded on August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Corlanor 5 mg tablets (60-count units) with a ceiling value of $14,988.19. This firm fixed-price delivery order, which carries an ultimate completion date of August 21, 2025, represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Corlanor (ivabradine) is a cardiac medication used to treat heart...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, valued at $3,636.97. The award, made on August 26, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,664.37 for 60 tablets of Corlanor 5 mg on August 21, 2025, with completion scheduled for August 22, 2025. The contract employs firm fixed pricing and was awarded on a non-set-aside basis through open competition. The award was funded by the Defense Medical Supply Chain, reflecting the federal government's reliance on AmerisourceBergen as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) valued at $2,313.94. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Corlanor 5 mg tablets (60-count units) at a ceiling value of $3,437.02. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). Corlanor (ivabradine) is a heart rate-reducing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,197.68 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) with a completion date of April 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.18 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing federal contract portfolio with DLA. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg with a ceiling value of $1,955.30. This firm fixed price, non-set-aside contract was awarded on September 4, 2025, with an ultimate completion date of September 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a typical transaction under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,265.42 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFKCDelivery Order
The Defense Logistics Agency awarded a $3,989.52 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with an ultimate completion date of July 28, 2025. This is a firm fixed price, non-set-aside contract classified as a child award, indicating it derives from a larger contract vehicle. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen leverages this comprehensive IDC to supply military and veteran healthcare systems with a wide range of pharmaceuticals, medical devices, and specialized healthcare commodities globally. Corlanor (ivabradine), a heart rate-lowering medication used in cardiology, represents one of many brand-name pharmaceutical products the company delivers through its extensive federal medical supply contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/25/25 |